Literature DB >> 2350918

HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.

F Esteban1, F Ruiz-Cabello, A Concha, M Pérez-Ayala, J A Sánchez-Rozas, F Garrido.   

Abstract

We studied class II antigen expression and tumor-infiltrating leukocytes (TIL) in tissue sections of 69 squamous cell carcinomas of the larynx and 24 lymph node metastases in the neck. HLA-DR expression was found only in eight well-differentiated, highly keratinizing squamous cell carcinomas comprising seven of the verrucous variety and one ventriculosaccular tumor. None of the metastases was positive for DR antigen. Neither primary tumors nor autologous metastases stained for DP or DQ antigens. DR-positive tumors shared a peculiar pattern of TIL composed mainly of T cells, most of which belonged to the cytotoxic/suppressor subset, and B cells. These neoplasms had in common a slow rate of growth, and are considered low-grade carcinomas in the literature. We conclude from our study that HLA-DR expression seems to characterize tumors with a prominent infiltrate and an excellent prognosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2350918     DOI: 10.1007/bf01810678

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  44 in total

1.  Expression of class I and class II major histocompatibility complex antigens on oral mucosal epithelium.

Authors:  N W Savage; L J Walsh; G J Seymour
Journal:  J Oral Pathol       Date:  1987-03

Review 2.  Role of MHC gene products in immune regulation.

Authors:  B Benacerraf
Journal:  Science       Date:  1981-06-12       Impact factor: 47.728

3.  Selective loss of HLA-A,B,C locus products in colorectal adenocarcinoma.

Authors:  M E Smith; W F Bodmer; J G Bodmer
Journal:  Lancet       Date:  1988-04-09       Impact factor: 79.321

4.  Expression of Ia antigen on epidermal keratinocytes in graft-versus-host disease.

Authors:  I A Lampert; A J Suitters; P M Chisholm
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

5.  Association of colorectal tumor epithelium expressing HLA-D/DR with CD8-positive T-cells and mononuclear phagocytes.

Authors:  C A Allen; N Hogg
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

6.  Intraepithelial lymphocytes modulate Ia expression by intestinal epithelial cells.

Authors:  N Cerf-Bensussan; A Quaroni; J T Kurnick; A K Bhan
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

7.  Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells.

Authors:  P G Natali; P Giacomini; A Bigotti; K Imai; M R Nicotra; A K Ng; S Ferrone
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

8.  Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness.

Authors:  J Gutierrez; M A López-Nevot; T Cabrera; R Oliva; J Esquivias; F Ruiz-Cabello; F Garrido
Journal:  Exp Clin Immunogenet       Date:  1987

9.  Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.

Authors:  F Esteban; A Concha; C Huelin; M Pérez-Ayala; S Pedrinaci; F Ruiz-Cabello; F Garrido
Journal:  Int J Cancer       Date:  1989-03-15       Impact factor: 7.396

10.  Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses.

Authors:  A P Albino; A N Houghton; M Eisinger; J S Lee; R R Kantor; A I Oliff; L J Old
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  22 in total

1.  HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker.

Authors:  Giuseppe Sconocchia; Serenella Eppenberger-Castori; Inti Zlobec; Eva Karamitopoulou; Roberto Arriga; Andrea Coppola; Sara Caratelli; Giulio Cesare Spagnoli; Davide Lauro; Alessandro Lugli; Junyi Han; Giandomenica Iezzi; Cristina Ferrone; Amedeo Ferlosio; Luigi Tornillo; Raoul Droeser; Piero Rossi; Antonio Attanasio; Soldano Ferrone; Luigi Terracciano
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

Review 2.  HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance.

Authors:  Barbara Seliger; Matthias Kloor; Soldano Ferrone
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

3.  PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma.

Authors:  Francesco Sabbatino; Vincenzo Villani; Jennifer H Yearley; Vikram Deshpande; Lei Cai; Ioannis T Konstantinidis; Christina Moon; Sjoerd Nota; Yangyang Wang; Ahmad Al-Sukaini; Andrew X Zhu; Lipika Goyal; David T Ting; Nabeel Bardeesy; Theodore S Hong; Carlos Fernandez-del Castillo; Kenneth K Tanabe; Keith D Lillemoe; Soldano Ferrone; Cristina R Ferrone
Journal:  Clin Cancer Res       Date:  2015-09-15       Impact factor: 12.531

4.  Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.

Authors:  T Rodríguez; R Méndez; A Del Campo; N Aptsiauri; J Martín; G Orozco; G Pawelec; D Schadendorf; F Ruiz-Cabello; F Garrido
Journal:  Immunogenetics       Date:  2006-12-20       Impact factor: 2.846

5.  The loss of class II MHC antigen expression by ras-transformed murine fibroblasts passaged as tumours correlates with increased tumorigenicity but is not mediated by T cells.

Authors:  A G Morris; R L Darley; W J Bateman
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Activation by interferon-gamma of expression of ICAM-1 and MHC class II antigens in tumour cells from colorectal carcinomas.

Authors:  I Donnellan; J Cantrill; I Fraser; A Morris
Journal:  Clin Mol Pathol       Date:  1995-02

7.  Induction of intercellular adhesion molecule 1 and class II histocompatibility antigens in colorectal tumour cells expressing activated ras oncogene.

Authors:  V Stoneman; A Morris
Journal:  Clin Mol Pathol       Date:  1995-12

8.  The role of major histocompatibility complex expression on head and neck cancer cells in the induction of autologous cytotoxic T lymphocytes.

Authors:  K Chikamatsu; M Eura; H Matsuoka; H Murakami; T Fukiage; T Ishikawa
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

9.  The effect of class II gene transfection on the tumourigenicity of the H-2K-negative mouse leukaemia cell line K36.16.

Authors:  R F James; S Edwards; K M Hui; P D Bassett; F Grosveld
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

10.  Loss of human leucocyte antigen class I and gain of class II expression are early events in carcinogenesis: clues from a study of Barrett's oesophagus.

Authors:  S Rajendra; R Ackroyd; N Karim; C Mohan; J J Ho; M K Kutty
Journal:  J Clin Pathol       Date:  2006-02-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.